• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医生报告采取的减少丁丙诺啡转用的步骤。

Steps physicians report taking to reduce diversion of buprenorphine.

机构信息

Department of Psychiatry and Behavioral Neurosciences, University of Chicago, IL 60615, USA.

出版信息

Am J Addict. 2013 May-Jun;22(3):184-7. doi: 10.1111/j.1521-0391.2012.00335.x.

DOI:10.1111/j.1521-0391.2012.00335.x
PMID:23617857
Abstract

BACKGROUND AND OBJECTIVES

Physicians are challenged to effectively treat opioid dependent patients while minimizing diversion of potentially abusable medications, such as buprenorphine. The present study was designed to obtain information on steps physicians report taking to reduce diversion of buprenorphine.

METHOD

National quarterly surveys from 2008 to 2009 of qualified physicians who have prescribed buprenorphine were analyzed (N = 2,330). One part of the survey queried physicians about what steps they had taken to reduce abuse and diversion of buprenorphine from a pre-specified list of 12 steps. Other parts of the survey included questions on the physicians' training and experience.

RESULTS

Physicians reported taking a mean of 4.4 steps. Longer experience prescribing buprenorphine, more buprenorphine-related educational training, and concern about diversion as a limitation on using buprenorphine for maintenance were associated with higher number of steps taken.

CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE

Physicians are currently taking multiple steps to reduce diversion. Future research needs to verify if these steps are effective or are instead reducing access to treatment.

摘要

背景和目的

医生在有效治疗阿片类药物依赖患者的同时,还需尽量减少潜在滥用药物(如丁丙诺啡)的转用。本研究旨在获取医生为减少丁丙诺啡转用而采取措施的相关信息。

方法

对 2008 年至 2009 年期间开具丁丙诺啡处方的合格医生进行了全国季度调查(n=2330)。调查的一部分询问医生从预先确定的 12 个步骤中采取了哪些措施来减少丁丙诺啡的滥用和转用。调查的其他部分包括有关医生培训和经验的问题。

结果

医生报告平均采取了 4.4 个步骤。开丁丙诺啡处方的经验更丰富、与丁丙诺啡相关的教育培训更多、以及对转用作为使用丁丙诺啡进行维持治疗的限制的关注,与采取的步骤数量更多有关。

结论和科学意义

医生目前正在采取多项措施来减少转用。未来的研究需要验证这些措施是否有效,或者是否反而会减少治疗的可及性。

相似文献

1
Steps physicians report taking to reduce diversion of buprenorphine.医生报告采取的减少丁丙诺啡转用的步骤。
Am J Addict. 2013 May-Jun;22(3):184-7. doi: 10.1111/j.1521-0391.2012.00335.x.
2
Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.早期职业医生和即将毕业的医生更有可能开丁丙诺啡处方。
J Am Board Fam Med. 2020 Jan-Feb;33(1):7-8. doi: 10.3122/jabfm.2020.01.190230.
3
Buprenorphine prescribing practice trends and attitudes among New York providers.纽约医疗服务提供者丁丙诺啡的处方开具实践趋势及态度
J Subst Abuse Treat. 2017 Mar;74:1-6. doi: 10.1016/j.jsat.2016.10.005. Epub 2016 Oct 29.
4
Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.克服开具丁丙诺啡用于治疗阿片类药物使用障碍的障碍:农村医生的建议。
J Rural Health. 2019 Jan;35(1):113-121. doi: 10.1111/jrh.12328. Epub 2018 Oct 19.
5
Trends In Buprenorphine Prescribing By Physician Specialty.医生专业的丁丙诺啡处方趋势。
Health Aff (Millwood). 2019 Jan;38(1):24-28. doi: 10.1377/hlthaff.2018.05145.
6
Practice Predictors of Buprenorphine Prescribing by Family Physicians.家庭医生开出丁丙诺啡处方的实践预测因素。
J Am Board Fam Med. 2020 Jan-Feb;33(1):118-123. doi: 10.3122/jabfm.2020.01.190235.
7
Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.家庭医生采用丁丙诺啡维持疗法的障碍分析。
Rural Remote Health. 2015;15:3019. Epub 2015 Feb 4.
8
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.美沙酮处方医师人数与医疗补助计划参保者美沙酮治疗使用和处方类阿片药物使用的关联。
JAMA Netw Open. 2018 Sep 7;1(5):e182943. doi: 10.1001/jamanetworkopen.2018.2943.
9
Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.美国美沙酮处方医生对患者的关注程度。
JAMA. 2021 Jun 1;325(21):2206-2208. doi: 10.1001/jama.2021.4469.
10
Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.2007 - 2017年美国丁丙诺啡豁免处方医生的增长与分布情况
Ann Intern Med. 2020 Apr 7;172(7):504-506. doi: 10.7326/M19-2403. Epub 2020 Jan 7.

引用本文的文献

1
Bridging the Macro-micro Divide: A Qualitative Meta-synthesis on the Perspectives and Experiences of Health Care Providers on the Extramedical Use and Diversion of Buprenorphine.弥合宏观-微观鸿沟:医疗保健提供者对丁丙诺啡的非医疗使用和转用的观点和经验的定性元分析。
J Addict Med. 2023;17(1):e1-e10. doi: 10.1097/ADM.0000000000001020. Epub 2022 Aug 2.
2
A mixed methods study of provider factors in buprenorphine treatment retention.一项关于丁丙诺啡治疗保留中提供者因素的混合方法研究。
Int J Drug Policy. 2022 Jul;105:103715. doi: 10.1016/j.drugpo.2022.103715. Epub 2022 May 6.
3
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program.
评估丁丙诺啡处方和阿片类药物相关健康结果后扩大丁丙诺啡豁免计划。
J Subst Abuse Treat. 2022 Jan;132:108452. doi: 10.1016/j.jsat.2021.108452. Epub 2021 Apr 30.
4
Therapy without a prescription: buprenorphine/naloxone diversion and the therapeutic assemblage in Taiwan.无需处方的治疗:丁丙诺啡/纳洛酮的转移和在台湾的治疗组合。
Sociol Health Illn. 2020 Mar;42(3):596-609. doi: 10.1111/1467-9566.13045. Epub 2019 Dec 13.
5
US physicians' decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progress.美国医生在丁丙诺啡-纳洛酮治疗中的决策:基于患者进展的剂量和就诊调整的联合分析。
Drug Alcohol Depend. 2019 Nov 1;204:107490. doi: 10.1016/j.drugalcdep.2019.05.022. Epub 2019 Aug 30.
6
A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.一项关于安非他酮和丁丙诺啡对减少甲基苯丙胺渴望效果的随机临床试验。
Trials. 2019 Jul 30;20(1):468. doi: 10.1186/s13063-019-3554-6.
7
Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?揭开丁丙诺啡滥用的神秘面纱:对药物转移的恐惧是否阻碍了阿片类药物危机的解决?
Subst Abus. 2019;40(2):148-153. doi: 10.1080/08897077.2019.1572052. Epub 2019 Apr 22.
8
Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.提供者和患者对丁丙诺啡依从性障碍的看法,以及视频直接观察治疗以提高依从性的可接受性。
Addict Sci Clin Pract. 2019 Mar 13;14(1):11. doi: 10.1186/s13722-019-0139-3.
9
MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study.MySafeRx:一种移动技术平台,整合了激励性辅导、依从性监测和电子药丸配药,用于增强阿片类药物使用障碍治疗期间丁丙诺啡/纳洛酮的依从性:一项试点研究。
Addict Sci Clin Pract. 2018 Sep 24;13(1):21. doi: 10.1186/s13722-018-0122-4.
10
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.解决美沙酮类物质处方障碍的政策途径。
Am J Prev Med. 2018 Jun;54(6 Suppl 3):S230-S242. doi: 10.1016/j.amepre.2017.12.022.